S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Orexigen Therapeutics Reports Results for the Third Quarter Ended September 30, 2014|
|Orexigen Therapeutics to Host Third Quarter 2014 Financial Results Conference Call and Webcast|
|Orexigen Therapeutics to Present at the Credit Suisse Healthcare Conference|
|Orexigen Therapeutics to Present at the Piper Jaffray Healthcare Conference|
|Orexigen Therapeutics to Present at the J.P. Morgan 2015 Healthcare Conference|
|Orexigen Announces Allowance of New U.S. Patent for Contrave® (naltrexone HCl / bupropion HCl extended release)|
|Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston|
|Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union|
Click above to view more mutual fund data and stats for orex - Orexigen Therapeutics Inc.